INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

73,241 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
IJ
Inson Paul JosephChief People Officer
IBEXIBEX Ltd
Grant or award
A—
5,000 sh
Oct 30, 2026Nov 3, 2026
Page 153 of 1832
← PrevNext →
traded Oct 30, 2026
+4d
SEC Form 4

Evidence

9
MR
Machin RobertDirector, Interim CEO
DAVAEndava plc
Grant or award
A—
66.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
SA
Sherrick Michael A.EVP & CHIEF FINANCIAL OFFICER
IIIInformation Services Group Inc.
Option exercise
M—
27.8K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
AM
Afdahl David MartinChief Operating Officer
IBEXIBEX Ltd
Grant or award
A—
9,500 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
OC
Ohlgart ChristianeChief Financial Officer
FTNTFortinet, Inc.
Tax withholding
F$106K
777 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
CK
Casteel Julie KChief Sales/Marketing Officer
IBEXIBEX Ltd
Grant or award
A—
9,500 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
SL
Stevens Blake L.Regional Market Director
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Tax withholding
F$11K
282 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
2,328 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC Form 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
42.5K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
DE
Dozier EricEVP, Chief People Officer
LLYELI LILLY & Co
Option exercise
M—
2,300 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
EC
Erb Thomas CDirector
POSTPost Holdings, Inc.
Grant or award
A$11K
134 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
PA
Peterman Catherine AChief People Officer
FFIVF5, INC.
Option exercise
M—
1,077 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
HE
Hernandez EdgardoEVP & Pres., Mfg. Operations
LLYELI LILLY & Co
Option exercise
M—
2,530 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
WB
White Tiffany B.Director
BUSEFIRST BUSEY CORP /NV/
Grant or award
A—
95 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
HA
Hammond Thomas AnthonyPresident, Busey Bank
BUSEFIRST BUSEY CORP /NV/
Grant or award
A—
114 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
KE
Kuriakose EmilDirector
MGNXMACROGENICS INC
Grant or award
A—
44.0K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
AK
Anand KunalChief Technology Officer
FFIVF5, INC.
Option exercise
M—
668 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
PA
Phillips Scott A.Chief Accounting Officer
BUSEFIRST BUSEY CORP /NV/
Grant or award
A—
79 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
OM
Okeke Angelique MEVP, General Counsel
FFIVF5, INC.
Option exercise
M—
334 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
BM
Boehm Jessica MSVP/General Counsel/Secretary
NONENONEHighlands REIT, Inc.
Grant or award
A—
10.34M sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
SC
Schelling ChristinaEVP & Chief People Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A—
11.2K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
JS
Jorstad Chip S.Chief Credit Officer
BUSEFIRST BUSEY CORP /NV/
Grant or award
A—
223 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
MR
Machin RobertDirector, Interim CEO
DAVAEndava plc
Option exercise
M—
1,154 sh
Oct 31, 2026Nov 3, 2026
traded Oct 31, 2026
+3dSEC Form 4

Evidence

9
DJ
Darwal Michael JosephChief AI & Digital Officer
IBEXIBEX Ltd
Grant or award
A—
7,000 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

9
NS
Nieves Michael SteinerEVP & Chief Financial Officer
INNSummit Hotel Properties, Inc.
Grant or award
A—
106.8K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

9
MR
Machin RobertDirector, Interim CEO
DAVAEndava plc
Tax withholding
F$7,263
4,686 sh
Oct 31, 2026Nov 3, 2026
traded Oct 31, 2026
+3dSEC Form 4

Evidence

9
OM
Okeke Angelique MEVP, General Counsel
FFIVF5, INC.
Option exercise
M—
250 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
AJ
Allaire JeremyDirector, Chairman and CEO
CRCLCircle Internet Group, Inc.
Tax withholding
F$610K
8,404 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Gift
G—
100.0K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

8
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Tax withholding
F$580K
7,989 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Tax withholding
F$277K
3,816 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Tax withholding
F$260K
12.0K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$247K
2,873 sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Tax withholding
F$57K
13.1K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

8
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Tax withholding
F$260K
12.0K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC Form 4

Evidence

7
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
400 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence

7
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$170K
9,412 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC Form 4

Evidence

7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
20.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC Form 4

Evidence

7
CJ
Chandrasekhar Rao JadcherlaSVP, Products and Services
EGANEGAIN Corp
Option exercise · 10b5-1 plan
M$15K
6,000 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC Form 4

Evidence

7
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
10.9K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC Form 4

Evidence